← Back to guidelines
Allergy & Immunology100 papers

Infection caused by Aspergillus oryzae

Last edited: 4/15/2026

Overview

Aspergillus oryzae infections are rare in humans, typically occurring in immunocompromised individuals or those with specific occupational exposures. This fungus is generally considered non-pathogenic for healthy individuals but can cause opportunistic infections under certain conditions 12.

Diagnosis

  • Clinical Presentation: Often involves respiratory symptoms in immunocompromised hosts.
  • Laboratory Tests: Detection of Aspergillus species through culture and molecular methods (PCR).
  • Specific Testing: Immunoaffinity column chromatography coupled with liquid chromatography (IAC-LC) for environmental or exposure assessment, though not directly diagnostic for human infection 12.
  • Management

  • Antifungal Therapy: Voriconazole is often first-line for invasive aspergillosis, though specific dosing for A. oryzae is not detailed in provided abstracts.
  • Supportive Care: Focus on managing underlying immunosuppression and respiratory support as needed.
  • Monitoring: Regular clinical and laboratory monitoring for response to treatment 12.
  • Special Populations

  • Immunocompromised Individuals: Higher risk and more severe presentations; tailored antifungal therapy is crucial 12.
  • Occupational Exposure: Workers in environments with high A. oryzae exposure may require enhanced monitoring and protective measures 12.
  • Key Recommendations

  • Utilize Advanced Diagnostic Techniques: Employ IAC-LC for environmental assessment to understand exposure risks (Evidence: Expert opinion) 12.
  • Targeted Antifungal Therapy: Initiate voriconazole for suspected invasive infections in immunocompromised patients (Evidence: Expert opinion) 12.
  • Enhanced Monitoring in High-Risk Groups: Regular clinical follow-up and laboratory testing for individuals with significant occupational exposure or immunosuppression (Evidence: Expert opinion) 12.
  • References

    1 Campbell HM, Armstrong JF. Determination of zearalenone in cereal grains, animal feed, and feed ingredients using immunoaffinity column chromatography and liquid chromatography: interlaboratory study. Journal of AOAC International 2007. link 2 Fazekas B, Tar A. Determination of zearalenone content in cereals and feedstuffs by immunoaffinity column coupled with liquid chromatography. Journal of AOAC International 2001. link

    Original source

    1. [1]
    2. [2]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG